{"slideshow_credits": null, "snippet": "The maker of Contrave released early results from a clinical trial that suggested the drug was more beneficial than it actually is, according to the researchers who oversaw the study.", "abstract": null, "section_name": "Business Day", "print_page": null, "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2015/05/13/business/data-disclosure-leads-researchers-to-end-study-of-obesity-drug.html", "lead_paragraph": "The maker of Contrave released early results from a clinical trial that suggested the drug was more beneficial than it actually is, according to the researchers who oversaw the study.", "headline": {"main": "Data Disclosure Leads Researchers to End Study of Obesity Drug"}, "_id": "5552b10938f0d86643ac571d", "word_count": "838", "multimedia": [], "pub_date": "2015-05-13T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Orexigen Therapeutics Inc", "is_major": "N", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "2"}, {"name": "subject", "value": "Obesity", "is_major": "N", "rank": "3"}, {"name": "subject", "value": "Clinical Trials", "is_major": "N", "rank": "4"}, {"name": "organizations", "value": "Cleveland Clinic", "is_major": "N", "rank": "5"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "N", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "News"}